Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
dc.contributor.author | Tichauer, Juan E. | |
dc.contributor.author | Arellano, Gabriel | |
dc.contributor.author | Acuna, Eric | |
dc.contributor.author | Gonzalez, Luis F. | |
dc.contributor.author | Kannaiyan, Nirmal R. | |
dc.contributor.author | Murgas, Paola | |
dc.contributor.author | Panadero-Medianero, Concepcion | |
dc.contributor.author | Ibanez-Vega, Jorge | |
dc.contributor.author | Burgos, Paula I. | |
dc.contributor.author | Loda, Eileah | |
dc.contributor.author | Miller, Stephen D. | |
dc.contributor.author | Rossner, Moritz J. | |
dc.contributor.author | Gebicke-Haerter, Peter J. | |
dc.contributor.author | Naves, Rodrigo | |
dc.date.accessioned | 2025-01-20T20:10:17Z | |
dc.date.available | 2025-01-20T20:10:17Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Compelling evidence has shown that interferon (IFN)-gamma has dual effects in multiple sclerosis and in its animal model of experimental autoimmune encephalomyelitis (EAE), with results supporting both a pathogenic and beneficial function. However, the mechanisms whereby IFN-gamma may promote neuroprotection in EAE and its effects on central nervous system (CNS)-resident cells have remained an enigma for more than 30 years. In this study, the impact of IFN-gamma at the peak of EAE, its effects on CNS infiltrating myeloid cells (MC) and microglia (MG), and the underlying cellular and molecular mechanisms were investigated. IFN-gamma administration resulted in disease amelioration and attenuation of neuroinflammation associated with significantly lower frequencies of CNS CD11b(+) myeloid cells and less infiltration of inflammatory cells and demyelination. A significant reduction in activated MG and enhanced resting MG was determined by flow cytometry and immunohistrochemistry. Primary MC/MG cultures obtained from the spinal cord of IFN-gamma-treated EAE mice that were ex vivo re-stimulated with a low dose (1 ng/ml) of IFN-gamma and neuroantigen, promoted a significantly higher induction of CD4(+) regulatory T (Treg) cells associated with increased transforming growth factor (TGF)-beta secretion. Additionally, IFN-gamma-treated primary MC/MG cultures produced significantly lower nitrite in response to LPS challenge than control MC/MG. IFN-gamma-treated EAE mice had a significantly higher frequency of CX3CR1(high) MC/MG and expressed lower levels of program death ligand 1 (PD-L1) than PBS-treated mice. Most CX3CR1(high)PD-L1(low)CD11b(+)Ly6G(-) cells expressed MG markers (Tmem119, Sall2, and P2ry12), indicating that they represented an enriched MG subset (CX3CR1(high)PD-L1(low) MG). Amelioration of clinical symptoms and induction of CX3CR1(high)PD-L1(low) MG by IFN-gamma were dependent on STAT-1. RNA-seq analyses revealed that in vivo treatment with IFN-gamma promoted the induction of homeostatic CX3CR1(high)PD-L1(low) MG, upregulating the expression of genes associated with tolerogenic and anti-inflammatory roles and down-regulating pro-inflammatory genes. These analyses highlight the master role that IFN-gamma plays in regulating microglial activity and provide new insights into the cellular and molecular mechanisms involved in the therapeutic activity of IFN-gamma in EAE. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.3389/fimmu.2023.1191838 | |
dc.identifier.issn | 1664-3224 | |
dc.identifier.uri | https://doi.org/10.3389/fimmu.2023.1191838 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/92058 | |
dc.identifier.wosid | WOS:001008567100001 | |
dc.language.iso | en | |
dc.revista | Frontiers in immunology | |
dc.rights | acceso restringido | |
dc.subject | multiple sclerosis | |
dc.subject | experimental autoimmune encephalomyelitis | |
dc.subject | interferon-gamma | |
dc.subject | microglia | |
dc.subject | myeloid cells | |
dc.subject | neuroinflammation | |
dc.subject | neurodegenerative disease | |
dc.subject | immune tolerance | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia | |
dc.type | artículo | |
dc.volumen | 14 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |